| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) (GALNT6) from ORIGENE TECHNOLOGIES | TP307728 | 20 ug | ORIGENE TECHNOLOGIES |
| Human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) (GALNT7) from ORIGENE TECHNOLOGIES | TP720818 | 10 ug | ORIGENE TECHNOLOGIES |
| Human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9), transcript variant B, full length from ORIGENE TECHNOLOGIES | TP760434 | 50 ug | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS507992 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS505130 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS508077 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS509738 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS521911 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS522510 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS518898 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS522534 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS522626 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS525399 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS525829 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS526085 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS526412 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS528328 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS528648 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS529542 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS530775 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS534803 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS534804 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS535501 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS538536 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS600432 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS606866 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS611405 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix, normal from ORIGENE TECHNOLOGIES | CS614181 | 5x5um | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 1 (PCDHA1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY410542 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 10 (PCDHA10), transcript variant 3 from ORIGENE TECHNOLOGIES | LY410465 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 11 (PCDHA11), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412914 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 13 (PCDHA13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412916 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 2 (PCDHA2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412917 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 3 (PCDHA3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412918 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 4 (PCDHA4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410492 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 5 (PCDHA5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412920 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 6 (PCDHA6), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412921 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 7 (PCDHA7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412922 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 8 (PCDHA8), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412923 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 9 (PCDHA9), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410462 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha 9 (PCDHA9), transcript variant 2 from ORIGENE TECHNOLOGIES | LY415536 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha subfamily C, 1 (PCDHAC1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412910 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin alpha subfamily C, 2 (PCDHAC2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410472 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin beta 1 (PCDHB1) from ORIGENE TECHNOLOGIES | LY415646 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin beta 12 (PCDHB12) from ORIGENE TECHNOLOGIES | LY412944 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin beta 13 (PCDHB13) from ORIGENE TECHNOLOGIES | LY412945 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin beta 14 (PCDHB14) from ORIGENE TECHNOLOGIES | LY412946 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin beta 15 (PCDHB15) from ORIGENE TECHNOLOGIES | LY412947 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin beta 16 (PCDHB16) from ORIGENE TECHNOLOGIES | LY412180 | 100 ug | ORIGENE TECHNOLOGIES |
| Protocadherin beta 2 (PCDHB2) from ORIGENE TECHNOLOGIES | LY412948 | 100 ug | ORIGENE TECHNOLOGIES |